Citation Impact
Citing Papers
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
2010 StandoutScience
Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation
2009
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
2010 Standout
Transition from inflammation to proliferation: a critical step during wound healing
2016 Standout
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Regulation of macrophage development and function in peripheral tissues
2015
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Proteasome inhibitors in cancer therapy
2017
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Chemotherapy-induced neuropathy: A comprehensive survey
2014
Flt3 Signaling-Dependent Dendritic Cells Protect against Atherosclerosis
2011 StandoutNobel
Features of the dendritic cell lineage
2010 StandoutNobel
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Non‐HLA genetics and predicting outcome in HSCT
2008
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System
2014
Mesenchymal stem cells in health and disease
2008 Standout
TFOS DEWS II Diagnostic Methodology report
2017 Standout
Tissue-resident macrophages
2013 Standout
Chronic graft-versus-host disease
2003 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Gene polymorphisms and transplantation
2001
Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia
2008
Association between a High-Expressing Interferon-γ Allele and a Lower Frequency of Kidney Angiomyolipomas in TSC2 Patients
2002
Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility
2006
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Graft-versus-host disease
2009 Standout
Tuberous sclerosis
2008 Standout
Systemic amyloidosis
2015 Standout
How were new medicines discovered?
2011 Standout
Origin and functional heterogeneity of non‐lymphoid tissue dendritic cells in mice
2010
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Molecular and epigenetic basis of macrophage polarized activation
2015
Hematopoietic Stem-Cell Transplantation
2006 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Genetic factors influencing the development of chronic graft-versus-host disease in a murine model
2000
Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
2012
Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
2011
Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells
2008
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
2012
Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible
2009
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
2006
Targeted protein degradation by PROTACs
2017
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Immunological reconstitution after hematopoietic cell transplantation – its relation to the contents of the graft
2008
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation
2003
P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation
2007
Risk assessment in haematopoietic stem cell transplantation: Pre–transplant patient and donor factors: non-HLA genetics
2007
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation
2002
Primary therapy of Waldenström macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)
2013
Development of Monocytes, Macrophages, and Dendritic Cells
2010 StandoutScience
Macrophage Polarization
2016 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Transforming growth factor-beta1 codon 10 polymorphism is associated with acute GVHD after allogenic BMT in Iranian population.
2007
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Dendritic cell homeostasis
2009
Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity
2017 StandoutNobel
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Immunology of Psoriasis
2014 Standout
Human dendritic cell subsets: an update
2018
Diversity, Mechanisms, and Significance of Macrophage Plasticity
2019 Standout
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
How I treat Waldenström macroglobulinemia
2015
Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1
2016 StandoutNobel
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
2016
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
2010 StandoutNobel
Ontogeny and homeostasis of Langerhans cells
2010
Wound Healing: A Cellular Perspective
2018 Standout
Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation
2006
Myeloma today: Disease definitions and treatment advances
2015
Human dendritic cell subsets
2013
A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma
2014
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men
2006
Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation
2010
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells
2007
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
Works of James Cavet being referenced
The fate of human Langerhans cells in hematopoietic stem cell transplantation
2006
Polymorphisms of interleukin‐1α constitute independent risk factors for chronic graft‐versus‐host disease after allogeneic bone marrow transplantation
2003
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
2011
Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation
2001
The Role of High Dose Chemotherapy and Autologous Stem Cell Transplantation In Patients with Multiple Myeloma Refractory to Initial Induction Therapy
2010
Recipient Tumor Necrosis Factor- and Interleukin-10 Gene Polymorphisms Associate With Early Mortality and Acute Graft-Versus-Host Disease Severity in HLA-Matched Sibling Bone Marrow Transplants
1999
Recipient Tumor Necrosis Factor- and Interleukin-10 Gene Polymorphisms Associate With Early Mortality and Acute Graft-Versus-Host Disease Severity in HLA-Matched Sibling Bone Marrow Transplants
1999